News
Circulating DNA has promise for cancer detection, but faces challenges
Unnecessary procedures and health care challenges could leave Whites as the primary beneficiaries.
News
Pembrolizumab monotherapy effective for rare melanoma
Patients with unresectable desmoplastic melanoma experienced a response rate that was nearly double other melanomas.
News
Type of insurance linked to length of survival after lung surgery
Having public or a combination of public and private insurance was associated with worse 10-year overall survival.
News
Thoracic cancer approvals differ at FDA, EMA
The EMA had fewer approvals and took longer to make decisions.
News
In metastatic NSCLC, better QoL outcomes tied to better outcomes
But the authors of new research also found potential evidence that industry sponsorship may lead to a spin on QoL outcomes.
News
Patients with IBD express need for psychosocial support
AGA launches My IBD Life campaign to support patients with IBD and encourage providers to play a role.
News
Patient-based mouse MVID model hints at mechanism
A method using gene editing at the two-cell stage recreated in mice the phenotype of a patient with two separate mutations.
News
Defensiveness may drive refusal for colon cancer screening
An Irish study pinpoints excuses for putting off screening and discounting one’s risk of colorectal cancer.
News
An earlier hep B biomarker for clinical outcomes?
Levels of a core-related antigen marker plunge years before a drop in the surface antigen, finds a natural history study of patients with chronic...
News
MS looks homogeneous
An analysis of clinical factors and treatment responses calls for personal rather than precision medicine.
News
Portable MRI has potential for MS
A blinded study showed good agreement with high-field MRI for some applications, but more development is needed.
News
A better MS measure?
A ‘digital carpet’ may provide more granular information about functional decline in patients with MS.
News
MOGAD: Immunotherapy predicts fewer relapses
IVIG therapy appears to be the most effective for reducing relapses.
News
To prevent MS, should we target EBV?
Can a vaccine against EBV reduce MS incidence on a population level? Two experts debate.
News
Differential diagnosis in MS: What to watch for
‘Red flags’ suggest something other than MS.